Electrostatic medium effects and formal quantum structure-activity relationships in apomorphines interacting with D1 and D2 dopamine receptors

International Journal of Quantum Chemistry

Volumn 61, Issue 6, 1997, Pages 997-1002

  Gómez Jeria, Juan Sebastián ^a   Ojeda Vergara, Mario ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038324750     PISSN: 00207608     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-461X(1997)61:6<997::AID-QUA12>3.3.CO;2-K     Document Type: Article

References (33)

1. G. J. LaHoste and J. F. Karshall, Ann. N.Y. Acad. Sci. 702, 183 (1993).
2. P. Sokoloff, B. Giros, M. P. Martres, M. L. Bouthenet, and J. C. Schwartz, Nature 347, 146 (1990).
3. G. Yigong, J. R. Vishnu, A. Campbell, N. S. Kula, J. R. Baldessarini, and J. L. Neumeyer, J. Med. Chem. 33, 39 (1990).
4. F. J. de Castro, R. W. Jaeger, A. Peters, V. T. Rolfe, C. Lorenz, and R. Lauritsen, Clin. Toxicol. 12, 65 (1978).
5. J. Braham, I. Sarova-Pinhar, and Y. Goldharnmer, Br. Med. J. 3, 768 (1979).
6. S. Lal, C. E. de la Vega, T. L. Sourkes, and H. G. Friesen, Lancet 2, 661 (1972).
7. S. Lai and N. P. V. Nair, in Psychoneuroendocrine Dysfunction, N. S. Shah and A. G. Donald, Eds. (Plenum, New York, 1984), pp. 485-501.
8. P. S. Gupta, Chem. Rev. 89, 1765 (1989).
9. M. P. Seiler, R. Markstein, M. D. Walkinshaw, and J. J. Boelsterli, Mol. Pharmacol. 35, 643 (1989).
10. B. Testa, N. El Tayar, P. A. Carrupt. H. Van de Watelberg, G. J. Kilpatrick, P. Jenner, and C. D. Marden, J. Pharm. Pharmacol. 39, 767 (1987).
11. D. Hoyer, D. E. Clarke, J. R. Fozard, P. R. Hartig, G. R. Martin, E. J. Mylecharana, P. R. Saxena, and P. A. Humphrey, Pharmacol, Rev. 46, 157 (1994).
12. J. M. Walker, W. D. Bowen, F. O. Walker, R. T. Matsumoto, B. de Costa, and K. C. Rice, Pharmacol. Rev. 42, 355 (1990).
13. J. S. Gómez-Jeria, Int. J. Quantum Chem. 23, 1969 (1983).
14. J. S. Gómez-Jeria, in Molecules in Physics, Chemistry and Biology, J. Maruani, Ed. (Kluwer, Dordrecht, 1989), Vol. 4, pp. 231-251.
15. J. S. Gómez-Jeria and D. Morales-Lagos, in QSAR in Design of Bioactive Compounds, M. Kuchar, Ed. (J. R. Prous, Barcelona, 1984), pp. 145-173.
16. J. S. Gómez-Jeria and D. Morales-Lagos, J. Phar. Sci. 73, 1725 (1984).
17. J. S. Gómez-Jeria,D. Morales-Lagos, B. K. Cassels, and J. C. Saavedra-Aguilar, Quantum Struct.-Act. Relat. 5, 153 (1986).
18. J. S. Gómez-Jeria, J. I. Rodriguez-Gatica, D. Morales-Lagos, and J. C. Saavedra-Aguilar, Int. J. Quantum Chem. 28, 421 (1986).
19. J. S. Gómez-Jeria and P. Sotomayor, J. Mol. Struct. (Theochem) 166, 493 (1988).
20. J. S. Gómez-Jeria, C. Donoso-Espinoza, and M. Ojeda-Vergara, J. Mol. Eng. 5, 391 (1996).
21. J. S. Gómez-Jeria, B. K. Cassels, and J. C. Saavedra-Aguilar, Eur. J. Med. Chem. 22, 433 (1987).
22. R. Contreras and J. S. Gómez-Jeria, J. Phys. Chem. 88, 1905 (1984).
23. J. S. Gómez-Jeria and R. Contreras, Int. J. Quantum Chem. 30, 581 (1986).
24. J. S. Gómez-Jeria, J. Parra-Mouchet, and D. Morales-Lagos, J. Mol. Struct. (Theochem) 236, 201 (1991).
25. J. S. Gómez-Jeria, J. Parra-Mouchet, and D. Morales-Lagos, Int. J. Quantum Chem. 40, 299 (1991).
26. J. S. Gómez-Jeria, II Farmaco, 40, 299 (1985).
27. J. S. Gómez-Jeria, J. Pharm. Sci. 71, 1423 (1982).
28. B. W. Clare, J. Med. Chem. 33, 687 (1990).
29. K. Fukui, T. Yonezawa, C. Nagata, and N. Shingu, J. Chem. Phys. 22, 1433 (1954).
30. K. Fukui, T. Yonezawa, and C. Nagata, Bull. Chem. Soc. Jpn. 27, 423 (1954).
31. I. Fleming, Frontier Orbitals and Organic Chemical Reactions (Wiley, London, 1976).
32. D. T. Manallack and P. M. Beart, J. Pharm. Pharmacol. 40, 422 (1988).
33. L. Lagos-Arancibia, Thesis (Faculty of Chemical and Pharmaceutical Sciences, University of Chile, 1995).